You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL1

Showing 76 - 100 of 745
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microsatellite Stable Colorectal Carcinoma, Platinum Resistant Epithelial Ovarian Cancer Type II, Estrogen Receptor Positive and

Completed
  • Microsatellite Stable Colorectal Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 30, 2021

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Lung Cancer Trial in France (Assessment of PDL1 expression)

Unknown status
  • Lung Cancer
  • Assessment of PDL1 expression
  • Argenteuil, VAL D'oise, France
  • +12 more
Mar 13, 2020

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2021

Circulating Tumor Cells in Non-small Cell Lung Cancer

Recruiting
  • Lung Cancer
  • blood sample collection for CTC and MDSC analysis
  • Toulouse, France
    Larrey Hospital
Nov 18, 2020

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Esophageal Cancer, Stage II, Esophageal Cancer Stage III Trial in Amsterdam (Atezolizumab, Carboplatin, Paclitaxel)

Completed
  • Esophageal Cancer, Stage II
  • Esophageal Cancer Stage III
  • Amsterdam, Netherlands
    Academic Medical Center, Medical Oncology
May 8, 2020

Breast Adenocarcinoma, Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (Atezolizumab,

Active, not recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

Non-small-cell Lung Cancer Trial in France (Pembrolizumab, Pembrolizumab and Chemotherapy drugs)

Recruiting
  • Non-small-cell Lung Cancer
  • Aix-en-Provence, France
  • +30 more
Mar 10, 2021

Texture Features and PDL1 in CT-PET 18 FDG

Completed
  • Non Small Cell Lung Cancer
    • Montpellier, France
      Uh Montpellier
    Mar 16, 2020

    Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

    Active, not recruiting
    • Melanoma
    • +7 more
    • Scottsdale, Arizona
    • +36 more
    Dec 22, 2022

    NSCLC Metastatic Trial in France (Ipilimumab, Nivolumab)

    Active, not recruiting
    • Non-Small Cell Lung Cancer Metastatic
    • Amiens, France
    • +46 more
    Mar 9, 2022

    Small Cell Lung Cancer, Small Cell Lung Cancer Limited Stage, Small Cell Lung Cancer Extensive Stage Trial in France

    Completed
    • Small Cell Lung Cancer
    • +2 more
    • Ambilly, France
    • +17 more
    Feb 9, 2021

    Invasive Ductal Breast Carcinoma Trial in Worldwide (Carboplatin, Abraxane, MPDL3280A)

    Active, not recruiting
    • Invasive Ductal Breast Carcinoma
    • Innsbruck, Austria
    • +40 more
    Jul 26, 2022

    Glioblastoma Multiforme Trial

    Unknown status
    • Glioblastoma Multiforme
      • (no location specified)
      Feb 22, 2020

      Non Small Cell Lung Cancer Trial in Detroit (drug, diagnostic test, other)

      Unknown status
      • Non Small Cell Lung Cancer
      • Detroit, Michigan
        Henry Ford Health Systems
      Mar 25, 2020

      Non Small Cell Lung Cancer Trial in Rouen (PET scan imaging)

      Recruiting
      • Non Small Cell Lung Cancer
      • PET scan imaging
      • Rouen, France
      • +1 more
      Jul 29, 2020

      Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage

      Recruiting
      • Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
      • +2 more
      • Therapeutic Conventional Surgery
      • +3 more
      • Aurora, Colorado
      • +82 more
      Jan 24, 2023

      Safety of Malignant Pleural Mesothelioma, Treated by

      Completed
      • Malignant Pleural Mesothelioma
      • Data collection
      • Bayonne, France
      • +4 more
      Feb 3, 2022

      Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite Trial in United States (QWO™(CCH-aaes) + No Mitigation Treatment,

      Completed
      • Edematous Fibrosclerotic Panniculopathy (EFP)
      • Cellulite
      • QWO™(CCH-aaes) + No Mitigation Treatment
      • +5 more
      • Scottsdale, Arizona
      • +7 more
      Nov 2, 2021

      Lung Cancer Trial in Spain (Pembrolizumab)

      Recruiting
      • Lung Cancer
      • Elche, Alicante, Spain
      • +18 more
      Jan 9, 2023

      Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)

      Active, not recruiting
      Has Results
      • Lymphoma
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Gilbert, Arizona
      • +53 more
      Jan 25, 2022

      NSCLC, Metastatic Lung Non-Small Cell Carcinoma, Non Small Cell Lung Cancer Trial (Palliative Radiotherapy: 5 x 4Gy, chemo +

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Palliative Radiotherapy: 5 x 4Gy
      • chemotherapy + immune checkpoint inhibitors
      • (no location specified)
      Jun 27, 2022

      Ovarian Tumors Trial in Worldwide (Bevacizumab, atezolizumab, acetylsalicylic acid)

      Active, not recruiting
      • Ovarian Neoplasms
      • Paris, France
      • +11 more
      Jul 30, 2020